Moviprep and Finasteride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Finasteride (finasteride). Common drug interactions include neuroleptic malignant syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Finasteride. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Finasteride?

Finasteride has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 44,177 Finasteride users. Check the latest studies of Finasteride.

On Aug, 12, 2026

27 people who take Moviprep and Finasteride together, and have interactions are studied.

Moviprep and Finasteride drug interactions.

What are the common drug interactions of Moviprep and Finasteride, by gender? *:

female:

n/a

male:

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Hyperhidrosis (abnormally increased sweating)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
Somnolence (a state of near-sleep, a strong desire for sleep)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Blood creatine phosphokinase increased
Cardiac failure
Chronic kidney disease
Dizziness

What are the common drug interactions of Moviprep and Finasteride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Drug ineffective

60+:

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Hyperhidrosis (abnormally increased sweating)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
Somnolence (a state of near-sleep, a strong desire for sleep)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Blood creatine phosphokinase increased
Cardiac failure
Chronic kidney disease
Dizziness

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 29.63%
Parkinson's Disease: 5 people, 18.52%
Renal Cell Carcinoma (a kidney cancer): 4 people, 14.81%
Constipation: 4 people, 14.81%
Nausea (feeling of having an urge to vomit): 4 people, 14.81%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 14.81%
Pneumonia: 3 people, 11.11%
Blood Calcium Decreased: 3 people, 11.11%
Chest Pain: 3 people, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Finasteride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously